The VAD Journal: The journal of mechanical assisted circulation and heart failure

Letter to the Editor

Should COVID Vaccination Be Required in Heart
Transplantation & Left Ventricular Assist Device
Implantation?
Mustafa M. Ahmed,1* Manjula G. Ananthram,2 Susan M. Joseph2

Citation: Ahmed, et al.
Should COVID Vaccination
Be Required in Heart
Transplantation & Left
Ventricular Assist Device
Implantation? The VAD
Journal. 2021; 7(1):e2021717.
https://doi.org/10.11589/vad/e
2021717
Editor-in-Chief: Maya Guglin,
University of Indiana
Received: October 3, 2021
Accepted: October 8, 2021
Published Online: October 21,
2021
©2021 The Author(s). This is an

open access article published
under the terms of the Creative
Commons AttributionNonCommercial 4.0 International
License
(https://creativecommons.org/lice
nses/by-nc/4.0/), which permits
unrestricted non-commercial use,
distribution, and reproduction in
any medium, provided that the
original author(s) and the
publication source are credited.
Funding: None
Competing interests: None

1

University of Florida, Division of Cardiovascular Medicine

2

University of Maryland, Division of Cardiovascular Medicine

*Corresponding author: mustafa.ahmed@medicine.ufl.edu

TO THE EDITOR: The COVID-19 pandemic has impacted global health like few
other crises in human history. According to the World Health Organization, more
than 230 million cases have been confirmed, resulting in more than 4.7 million
deaths worldwide.1 In the U.S. alone, over 43 million individuals have contracted
COVID-19 with more than 700,000 deaths.1
The far-reaching effects of the pandemic have also substantially impacted solid
organ transplantation. Organ donation rates have been reported to be decreased
by as much as 50-90% across a wide region of countries.2 Data from the United
Network of Organ Sharing (UNOS) demonstrated a decline of more than 1/3 in the
transplant rate in the early period of the pandemic, with a majority of UNOS
regions reporting an increase in waitlist mortality.3 A specific analysis of heart
transplantation in the US demonstrated a 75% increase in waitlist inactivation, a
reduction of 37% in waitlist additions, and a 26% decline in deceased donor
recovery when comparing to pre-pandemic data .4
Beyond its impact on transplant trends, COVID-19 has been ruthless in its
infection and spread, with many heart transplant recipients contracting the virus.
Hospitalization rates for heart transplant recipients with COVID-19 infection have
been reported to be as high as 80%, with a mortality approaching 30% in one
multicenter European analysis.5 A more recent systematic review, including 39
manuscripts and 415 patients, confirmed these findings with 77% of COVID
positive heart transplant recipients requiring hospitalization resulting in an inpatient
mortality of 25%.6
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These disturbing statistics have spurred professional societies to urge vaccinations
for not only those individuals who have received a solid organ transplant, but also
those who are being considered for the transplant waitlist. Unique to individuals
with end-stage heart failure, this also bears consideration for candidates being
evaluated for durable mechanical circulatory support (MCS) or left ventricular
assist devices (LVADs). The International Society of Heart and Lung
Transplantation (ISHLT) and American Society of Transplantation recently issued
a joint statement with the following recommendations:
i. All solid organ transplant recipients should be vaccinated
ii. All eligible household and close contacts should be
vaccinated
iii. Vaccination should occur prior to transplantation, with
completion of the series 2 weeks before when possible
The ISHLT has further recommended vaccination for all MCS recipients,
regardless of prior COVID-19 infection status. These recommendations are based
on the tremendous efficacy of vaccinations in preventing COVID-19 related
morbidity and mortality. Full vaccination has been demonstrated to be 89%
effective at preventing COVID-19 infection leading to hospitalization.7 This efficacy
has been documented across age groups as well as with the most recent Delta
variant.8
Despite the above data and recommendations, vaccine hesitancy remains a
problem, and individual providers as well as institutions are likely to have varied
perspectives and policies in regards to vaccination. We, therefore, sought to define
provider opinions and current institutional practices amongst transplant and LVAD
health care workers. This was achieved with a 5-question anonymous survey,
distributed via electronic communications, from September 17 – September 24,
2021. A total of 121 responses were available for analysis. The majority of
respondents (63%) were cardiologists involved in the care of heart transplant and
LVAD patients. A sizeable proportion of respondents indicated that their program
requires COVID-19 vaccination for patients to remain active on the transplant list
or in order to be listed, 42.9% and 41.4% respectively. Only 23.1% reported a
requirement for vaccination in patients awaiting LVAD implantation with even fewer
required vaccinations for the primary caregiver to the patient (12.9% for transplant
caregivers, 8.5% for LVAD caregivers). However, when asked for which
populations they would be in favor of mandating COVID-19 vaccinations, there
was overwhelming support for patients on the transplant list and those awaiting
LVAD implantation, 90.9% and 77.7% respectively. The majority of respondents
were also in support of a vaccine requirement for caregivers (80.2% for transplant
caregivers and 71.7% for LVAD caregivers). Support for vaccination requirements
in all four populations remained high when evaluating responses by role on the
heart transplant team (Figure).
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While there is largely agreement amongst providers that vaccinations should be
mandated for individuals who are awaiting advanced heart failure therapies, that
perhaps should extend to their caregivers; however, implementing such a policy
would be challenging. The ethical concerns include complex considerations
regarding the principles of autonomy, beneficence, and nonmaleficence, an
endeavor fraught with concerns and considerations. While mandates may
embrace the ethical principles of beneficence and nonmaleficence by promoting
societal well-being, reducing virus transmission risk, and protecting health care
workers and the sparse resource of a donated organ, it would undermine
autonomy. Furthermore, such a requirement would undoubtedly impact other
policy considerations in regard to both vaccinations as well as care giver behaviors
and expectations. Beyond this, a more challenging question which arises with
vaccination mandates may be the implications of such a change in policy to those
patients already listed. If programs and providers proceed to de-list individuals who
refuse to be vaccinated, how one addresses these vaccine hesitant candidates
would potentially disrupt the fairness and equity of the evaluation and listing
process. Finally, the possibility of having different expectations for transplant
candidates as compared to LVAD candidates, regardless of the intended implant
strategy for the latter, would be yet another policy and ethical conundrum.
While there are inherent limitations to any data acquired by survey, we feel that
these data provide a useful snapshot of perspectives among the transplant
community. Additionally, we were unable to distinguish whether or not more than
one respondent from the same institution answered the survey. As such, we
cannot yet conclude that most institutions require or wish to require vaccination.
The ethical and practical implications of vaccine mandates is certainly an area
which requires thoughtful and meticulous discussion as well as research.
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Differences in patient outcomes and factors such as patient satisfaction and
patient provider trust between institutions that mandate the vaccine and those that
do not would be key determinants in shaping policies surrounding vaccine
requirements. Tailored surveys deployed to program leadership as policies evolve
in this dynamic milieu, in addition to guidance from legal counsel, ethic committees
and professional societies will be instrumental in approaching this challenge. In the
interim, advanced heart failure providers should continue to broach the subject of
vaccination with their patients. Too often patients and providers fail to engage in
this exercise over concerns of the politicization and cultural perceptions of such
conversations. While we struggle with the challenges of polices and mandates, we
can always foster meaningful discussions with our patients and their caregivers.
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